AP
MED icon

Advisor Partners’s Medifast MED Stock Holding History

Advisor Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$362K Buy
+2,008
New +$359K 0.03% 578

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Advisor Partners's MED Position: Q2 2022 in Review

Advisor Partners opened a new position in Medifast (MED) in Q2 2022: 2,008 shares worth $362K. The stake represents 0.03% of the portfolio and ranks #578 among its holdings.

284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

  • Advisor Partners held 2,008 shares of Medifast worth $362K as of Q2 2022.
  • Medifast was a new Advisor Partners position in Q2 2022.
  • Medifast made up 0.03% of Advisor Partners's portfolio in Q2 2022, its #578 holding.
  • 284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.